Structural, functional, and molecular characterization of the SHHF model of heart failure

被引:80
作者
Heyen, JRR
Blasi, ER
Nikula, K
Rocha, R
Daust, HA
Frierdich, G
Van Vleet, JF
De Ciechi, P
McMahon, EG
Rudolph, AE
机构
[1] Pharmacia Corp, St Louis, MO 63167 USA
[2] Purdue Univ, Dept Vet Pathobiol, W Lafayette, IN 47907 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2002年 / 283卷 / 05期
关键词
echocardiography; inflammation; cytokines;
D O I
10.1152/ajpheart.00305.2002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure is a complex multifactorial disease resulting in a myriad of progressive changes at the molecular, cellular, and physiological level. To better understand the mechanisms associated with the development of congestive heart failure, a comprehensive examination of the aging lean male spontaneously hypertensive, heart failure-prone rat (SHHF) was conducted. Myocardial function and structural integrity progressively diminished as evidenced by decreased ejection fraction and increased left ventricular volume measured using echocardiography. Functional and structural changes were accompanied by elevations in circulating inflammatory markers, including tumor necrosis factor-alpha (TNF-alpha), IL-6, and TNF receptors type 1 and 2. Increased systemic inflammatory marker levels were consistent with age-dependent changes in the expression pattern of genes that contribute to stress, inflammation, and the extracellular matrix in SHHF animals analyzed from age 4 to 18 mo. In summary, the SHHF rat shares many hallmark features of the human disease state and represents a key experimental model for the dissection of complex human heart failure pathophysiology.
引用
收藏
页码:H1775 / H1784
页数:10
相关论文
共 39 条
[1]   Myocardial tumor necrosis factor-α secretion in hypertensive and heart failure-prone rats [J].
Bergman, MR ;
Kao, RH ;
McCune, SA ;
Holycross, BJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 277 (02) :H543-H550
[2]   Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure [J].
Bristow, MR ;
Gilbert, EM ;
Abraham, WT ;
Adams, KF ;
Fowler, MB ;
Hershberger, RE ;
Kubo, SH ;
Narahara, KA ;
Ingersoll, H ;
Krueger, S ;
Young, S ;
Shusterman, N .
CIRCULATION, 1996, 94 (11) :2807-2816
[3]   Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α [J].
Bryant, D ;
Becker, L ;
Richardson, J ;
Shelton, J ;
Franco, F ;
Peshock, R ;
Thompson, M ;
Giroir, B .
CIRCULATION, 1998, 97 (14) :1375-1381
[4]   Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure [J].
Colucci, WS ;
Packer, M ;
Bristow, MR ;
Gilbert, EM ;
Cohn, JN ;
Fowler, MB ;
Krueger, SK ;
Hershberger, R ;
Uretsky, BF ;
Bowers, JA ;
SacknerBernstein, JD ;
Young, ST ;
Holcslaw, TL ;
Lukas, MA .
CIRCULATION, 1996, 94 (11) :2800-2806
[5]   Heart failure survival among older adults in the United States - A poor prognosis for an emerging epidemic in the Medicare population [J].
Croft, JB ;
Giles, WH ;
Pollard, RA ;
Keenan, NL ;
Casper, ML ;
Anda, RF .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (05) :505-510
[6]   Effect of a selective aldosterone receptor antagonist in myocardial infarction [J].
Delyani, JA ;
Robinson, EL ;
Rudolph, AE .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (02) :H647-H654
[7]   OSTEOPONTIN - A PROTEIN WITH DIVERSE FUNCTIONS [J].
DENHARDT, DT ;
GUO, XJ .
FASEB JOURNAL, 1993, 7 (15) :1475-1482
[8]   Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival [J].
Denhardt, DT ;
Noda, M ;
O'Regan, AW ;
Pavlin, D ;
Berman, JS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (09) :1055-1061
[9]  
Deswal A, 2001, CIRCULATION, V103, P2055
[10]   Myocardial osteopontin expression is associated with left ventricular hypertrophy [J].
Graf, K ;
Do, YS ;
Ashizawa, N ;
Meehan, WP ;
Giachelli, CM ;
Marboe, CC ;
Fleck, E ;
Hsueh, WA .
CIRCULATION, 1997, 96 (09) :3063-3071